Illumina wins Grail battle in blow to EU merger power
By Foo Yun Chee BRUSSELS (Reuters) -U.S. gene sequencing company Illumina on Tuesday won its court fight against the European Union’s investigation of its $7.1 billion purchase of cancer diagnostic test maker Grail, a ruling set to curb Brussels’ merger powers. Illumina, which founded Grail and spun it off in 2016 only to re-acquire it …
Illumina wins Grail battle in blow to EU merger power Read More »









